Glenmark Pharmaceuticals’ arm to invest Rs 600 crore to double capacity in four years
Glenmark Pharmaceuticals’ arm — Glenmark Life Sciences is on track to more than double its capacity over the next four years at a cumulative investment of over Rs 600 crore. The capacity expansion is on the back of company’s plan to enter more regulated growth markets like Brazil, Mexico, Russia, Korea, Taiwan and Saudi Arabia. … Read more